Conservative therapy for inpatient hypertension bests antihypertensive intensification: JAMA
A research team of America suggests, in the absence of evidence of end-organ damage, conservative management was associated with improved outcomes compared with more intensive management for asymptomatic hypertension among hospitalized patients. The research has been published in the JAMA Internal Medicine on December 28, 2020.
Previous studies suggest that inpatient practitioners commonly intensify patients' antihypertensive regimens at hospital discharge, including patients with previously well-controlled outpatient BPs. This finding implies that clinical practice may largely be driven by reflexive responses to elevated inpatient recordings being continued at discharge rather than planned adjustment of outpatient regimens. Although evidence-based recommendations exist for outpatient management of hypertension, guidelines for treating inpatients with elevated blood pressure (BP) are lacking. Recent data suggest that a less-intensive approach is best. Because intensification of antihypertensive regimens is common in hospitalized and a subject of debate, understanding the actual benefits and harms of this practice is essential. For this purpose, researchers conducted a study to characterize clinician response to BP in the hospital and at discharge and to compare short- and long-term outcomes associated with antihypertensive treatment intensification.
It was an observational cohort study based on electronic medical record data from 2017 at 10 Cleveland Clinic hospitals. Researchers included 22,834 adults (mean age 65.6 years, 56.9% women, 69.9% White) admitted to a medicine service excluding those with cardiovascular diagnoses, like acute coronary syndrome and cerebrovascular accident, that require specific BP management. They used Demographic and BP characteristics for propensity matching. The major outcome assessed was the association between acute hypertension treatment and subsequent inpatient acute kidney injury, myocardial injury, and stroke. Postdischarge outcomes assessed were stroke and myocardial infarction within 30 days and BP control up to 1 year.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.